Immunological mechanisms of vaccine-induced protection against COVID-19 in humans.
Reads0
Chats0
TLDR
Most COVID-19 vaccines have been designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein this article.Abstract:
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including mRNA, adenoviral-vectored, protein subunit and whole-cell inactivated virus vaccines, have now reported efficacy in phase III trials and have received emergency approval in many countries. The two mRNA vaccines approved to date show efficacy even after only one dose, when non-NAbs and moderate T helper 1 cell responses are detectable, but almost no NAbs. After a single dose, the adenovirus vaccines elicit polyfunctional antibodies that are capable of mediating virus neutralization and of driving other antibody-dependent effector functions, as well as potent T cell responses. These data suggest that protection may require low levels of NAbs and might involve other immune effector mechanisms including non-NAbs, T cells and innate immune mechanisms. Identifying the mechanisms of protection as well as correlates of protection is crucially important to inform further vaccine development and guide the use of licensed COVID-19 vaccines worldwide.read more
Citations
More filters
Journal ArticleDOI
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
Mark W Tenforde,Wesley H. Self,Katherine Adams,Manjusha Gaglani,Adit A. Ginde,Tresa McNeal,Shekhar Ghamande,David J. Douin,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Matthew C. Exline,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B Stubblefield,Adrienne Baughman,Kelsey N Womack,Jillian P. Rhoads,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Samantha M. Olson,Miwako Kobayashi,Jennifer R. Verani,Manish M. Patel,Influenza +58 more
TL;DR: In this article, the authors evaluated the association between vaccination with mRNA COVID-19 vaccines and hospitalization, and the association with progression to critical disease, using multivariable logistic regression.
Journal ArticleDOI
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Jia-mei Wei,Koen B. Pouwels,Nicole Stoesser,Philippa C Matthews,Ian Diamond,Ruth Studley,Emma Rourke,D. Cook,John I. Bell,John N Newton,Jeremy Farrar,Alison Howarth,Brian D. Marsden,Sarah Hoosdally,E Y Jones,David I. Stuart,Derrick W. Crook,Tim E. A. Peto,A. Sarah Walker,David W Eyre,Tina Thomas,Daniel Ayoubkhani,Russell C. Black,Anton Felton,M.J. Crees,Joel Jones,L. Lloyd,Esther Sutherland,Emma Pritchard,Karina-Doris Vihta,George Doherty,James Kavanagh,Kevin K Chau,Stephanie B Hatch,Daniel Ebner,Lucas Martins Ferreira,Thomas Christott,Wanwisa Dejnirattisai,Juthathip Mongkolsapaya,Sarah Cameron,Phoebe Tamblin-Hopper,Magda Wolna,Rachael Brown,Richard J. Cornall,Gavin R. Screaton,Katrina A. Lythgoe,David Bonsall,Tanya Golubchik,Helen R. Fryer,Stuart Cox,K Paddon,Tim James,Thomas M. Boyd Jason R. House,Julie V. Robotham,Paul J Birrell,H. Jordan,Tim Sheppard,Graham Athey,Daniel S. Moody,Leigh Curry,P. J. Brereton,Ian Jarvis,Anna Godsmark,George Morris,Bobby Mallick,Phil Eeles,Jodie Hay,Harper C VanSteenhouse,Jessica Lee,Sean A. White,Tim S. Evans,Lisa Bloemberg,Katie Allison,Anouska Pandya,Sophie Frances Davis,David I. Conway,Margaret MacLeod,Chris Cunningham +77 more
TL;DR: In this article , the authors investigated anti-spike IgG antibody responses and correlates of protection after second doses of ChAdOx1 or BNT162b2 vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Journal ArticleDOI
COVID-19 vaccination: The road ahead
TL;DR: A diverse array of successful, first-generation SARS-CoV-2 vaccines have played a huge role in efforts to bring the COVID-19 pandemic under control, even though inequitable distribution still leaves many vulnerable.
Journal ArticleDOI
Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
Jinyi Tang,Cong Zeng,Thomas M Cox,Chaofan Li,Young Min Son,In Su Cheon,Yue-Jin Wu,Supriya Behl,Justin J. Taylor,Rana Chakaraborty,Aaron J. Johnson,Dante N. Shiavo,James P. Utz,Janani S. Reisenauer,David E. Midthun,John J. Mullon,Eric S. Edell,Mohamad-Gabriel Alameh,Larry Borish,W. Gerald Teague,Mark H. Kaplan,Drew Weissman,Ryan Kern,Haitao Hu,Robert Vassallo,Shan Lu,Jie Sun +26 more
TL;DR: This study supports the contention that the current COVID-19 vaccines are highly effective against severe disease development, likely through recruiting circulating B and T cell responses during re-infection, but offer limited protection against breakthrough infection, especially by Omicron sublineage.
Posted ContentDOI
Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant
Kasen K. Riemersma,Brittany E. Grogan,Amanda Kita-Yarbro,Gunnar E. Jeppson,David H. O’Connor,Thomas C. Friedrich,Katarina M. Grande +6 more
TL;DR: In Wisconsin, a large local contract laboratory provides SARS-CoV-2 testing for multiple local health departments, providing a single standard source of data using the same assay to measure virus burdens in test-positive cases as discussed by the authors.
References
More filters
Journal ArticleDOI
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann,Hannah Kleine-Weber,Simon Schroeder,Nadine Krüger,Tanja Herrler,Sandra Erichsen,Tobias S. Schiergens,Georg Herrler,Nai Huei Wu,Andreas Nitsche,Marcel A. Müller,Christian Drosten,Christian Drosten,Stefan Pöhlmann +13 more
TL;DR: It is demonstrated that SARS-CoV-2 uses the SARS -CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross-neutralized Sars-2-S-driven entry.
Journal ArticleDOI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P. Polack,Stephen J. Thomas,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Pérez Marc,Edson D. Moreira,Cristiano Zerbini,Ruth Bailey,Kena A. Swanson,Satrajit Roychoudhury,Kenneth Koury,Ping Li,Warren Kalina,David A. Cooper,Robert W. Frenck,Laura L. Hammitt,Özlem Türeci,Haylene Nell,Axel Schaefer,Serhat Ünal,Dina B. Tresnan,Susan Mather,Philip R. Dormitzer,Ugur Sahin,Kathrin U. Jansen,William C. Gruber +28 more
TL;DR: A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older and safety over a median of 2 months was similar to that of other viral vaccines.
Journal ArticleDOI
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
Daniel Wrapp,Nianshuang Wang,Kizzmekia S. Corbett,Jory A. Goldsmith,Ching-Lin Hsieh,Olubukola M. Abiona,Barney S. Graham,Jason S. McLellan +7 more
TL;DR: The authors show that this protein binds at least 10 times more tightly than the corresponding spike protein of severe acute respiratory syndrome (SARS)–CoV to their common host cell receptor, and test several published SARS-CoV RBD-specific monoclonal antibodies found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs.
WHO Declares COVID-19 a Pandemic.
TL;DR: The Director-General of the World Health Organization, Dr. Tedros Adhanom Ghebreyesus, noted that over the past 2 weeks, the number of cases outside China increased 13-fold and theNumber of countries with cases increased threefold, and further increases are expected.
Related Papers (5)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P. Polack,Stephen J. Thomas,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Pérez Marc,Edson D. Moreira,Cristiano Zerbini,Ruth Bailey,Kena A. Swanson,Satrajit Roychoudhury,Kenneth Koury,Ping Li,Warren Kalina,David A. Cooper,Robert W. Frenck,Laura L. Hammitt,Özlem Türeci,Haylene Nell,Axel Schaefer,Serhat Ünal,Dina B. Tresnan,Susan Mather,Philip R. Dormitzer,Ugur Sahin,Kathrin U. Jansen,William C. Gruber +28 more
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R. Baden,Hana M. El Sahly,Brandon Essink,Karen L. Kotloff,Sharon E. Frey,Rick Novak,David Diemert,Stephen A. Spector,Nadine Rouphael,C. Buddy Creech,John W McGettigan,Shishir Khetan,Nathan Segall,Joel Solis,Adam Brosz,Carlos Fierro,Howard J. Schwartz,Kathleen M. Neuzil,Lawrence Corey,Peter B. Gilbert,Holly Janes,Dean Follmann,Mary A. Marovich,John R. Mascola,Laura Polakowski,Julie E. Ledgerwood,Barney S. Graham,Hamilton Bennett,Rolando Pajon,Conor Knightly,Brett Leav,Weiping Deng,Honghong Zhou,Shu Liang Han,Melanie Ivarsson,Jacqueline Miller,Tal Z Zaks +36 more
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey,Clemens Sac.,Shabir A. Madhi,Lily Yin Weckx,P M Folegatti,Parvinder K. Aley,Brian Angus,Vicky L. Baillie,Shaun Barnabas,Q E Bhorat,S Bibi,Carmen Briner,P Cicconi,Andrea M. Collins,R Colin-Jones,Clare L. Cutland,Thomas C. Darton,Keertan Dheda,Duncan Cja.,Emary Krw.,Katie J. Ewer,Lee Fairlie,Saul N. Faust,Shuo Feng,Daniela M. Ferreira,Adam Finn,Anna Goodman,Catherine M. Green,Christopher A Green,Paul T. Heath,Christopher Hill,Helen Hill,Ian Hirsch,Hodgson Shc.,Allen Izu,S Jackson,D Jenkin,Joe Ccd.,S Kerridge,Anthonet Koen,Gaurav Kwatra,Rajeka Lazarus,Alison M. Lawrie,A Lelliott,Vincenzo Libri,Patrick J. Lillie,R Mallory,Mendes Ava.,Eveline Pipolo Milan,Angela M. Minassian,Alastair McGregor,Hazel Morrison,Y Mujadidi,Amit J Nana,P J O’Reilly,S D Padayachee,A Pittella,E Plested,Katrina M Pollock,M N Ramasamy,S Rhead,Alexandre Vargas Schwarzbold,Nisha Singh,Andrew Smith,R Song,Matthew D. Snape,Eduardo Sprinz,Rebecca K. Sutherland,R Tarrant,E. Thomson,M E Török,Mark Toshner,Turner Dpj.,Johan Vekemans,Tonya Villafana,Watson Mee.,C J Williams,Alexander D. Douglas,Hill Avs.,Teresa Lambe,Sarah C. Gilbert,Andrew J. Pollard +81 more